7PA5
Complex between the beta-lactamase CMY-2 with an inhibitory nanobody
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | SOLEIL BEAMLINE PROXIMA 1 |
| Synchrotron site | SOLEIL |
| Beamline | PROXIMA 1 |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2021-04-02 |
| Detector | DECTRIS EIGER X 16M |
| Wavelength(s) | 0.97856 |
| Spacegroup name | P 62 2 2 |
| Unit cell lengths | 95.120, 95.120, 242.940 |
| Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
| Resolution | 48.885 - 3.184 |
| R-factor | 0.209 |
| Rwork | 0.207 |
| R-free | 0.25020 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 1ZC2 (CMY-2) 6GKU (nanobody) |
| Data reduction software | XDS |
| Data scaling software | XSCALE |
| Phasing software | PHASER (2.8.2) |
| Refinement software | PHENIX (1.13_2998) |
Data quality characteristics
| Overall | Inner shell | Outer shell | |
| Low resolution limit [Å] | 48.885 | 48.885 | 3.370 |
| High resolution limit [Å] | 3.180 | 9.380 | 3.180 |
| Rmerge | 0.709 | 0.129 | 3.426 |
| Rmeas | 0.719 | 0.131 | 3.477 |
| Total number of observations | 437933 | ||
| Number of reflections | 11589 | 546 | 1758 |
| <I/σ(I)> | 7.09 | 25.84 | 1.28 |
| Completeness [%] | 99.6 | 99.1 | 97.9 |
| Redundancy | 37.789 | 31.923 | 34.761 |
| CC(1/2) | 0.999 | 1.000 | 0.429 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 8.5 | 293 | PEG400, glycerol, Ammonium tartarate, tris HCl, |






